Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma
Oral and esophageal squamous cell carcinomas harbor a diverse microbiome that differs
compositionally from precancerous and healthy tissues. Though causality is yet to be …
compositionally from precancerous and healthy tissues. Though causality is yet to be …
IGF binding proteins in cancer: mechanistic and clinical insights
RC Baxter - Nature Reviews Cancer, 2014 - nature.com
The six members of the family of insulin-like growth factor (IGF) binding proteins (IGFBPs)
were originally characterized as passive reservoirs of circulating IGFs, but they are now …
were originally characterized as passive reservoirs of circulating IGFs, but they are now …
Insulin-like growth factor (IGF) axis in cancerogenesis
A Kasprzak, W Kwasniewski, A Adamek… - … Research/Reviews in …, 2017 - Elsevier
Determination of the role of insulin-like growth factor (IGF) family components in
carcinogenesis of several human tumors is based on numerous epidemiological and pre …
carcinogenesis of several human tumors is based on numerous epidemiological and pre …
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer
W Liu, GP Rodgers - Cancer and Metastasis Reviews, 2016 - Springer
Abstract Olfactomedin 4 (OLFM4) is an olfactomedin domain-containing glycoprotein.
Multiple signaling pathways and factors, including NF-κB, Wnt, Notch, PU. 1, retinoic acids …
Multiple signaling pathways and factors, including NF-κB, Wnt, Notch, PU. 1, retinoic acids …
Factors secreted by cancer-associated fibroblasts that sustain cancer stem properties in head and neck squamous carcinoma cells as potential therapeutic targets
S Álvarez-Teijeiro, C García-Inclán, MÁ Villaronga… - Cancers, 2018 - mdpi.com
This study investigates for the first time the crosstalk between stromal fibroblasts and cancer
stem cell (CSC) biology in head and neck squamous cell carcinomas (HNSCC), with the …
stem cell (CSC) biology in head and neck squamous cell carcinomas (HNSCC), with the …
Potential role of epithelial–mesenchymal transition induced by periodontal pathogens in oral cancer
Y Ma, Y Yu, Y Yin, L Wang, H Yang… - Journal of Cellular …, 2024 - Wiley Online Library
With the increasing incidence of oral cancer in the world, it has become a hotspot to explore
the pathogenesis and prevention of oral cancer. It has been proved there is a strong link …
the pathogenesis and prevention of oral cancer. It has been proved there is a strong link …
Targeting insulin‐like growth factor binding protein‐3 signaling in triple‐negative breast cancer
Insulin‐like growth factor binding protein‐3 (IGFBP‐3) is a key regulatory molecule of the
IGF axis and can function in a tissue‐specific way as both a tumor suppressor and promoter …
IGF axis and can function in a tissue‐specific way as both a tumor suppressor and promoter …
Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma
CH Chen, PY Chen, YY Lin, LY Feng, SH Chen… - Journal of …, 2019 - thejns.org
OBJECTIVE Despite intensive medical treatment, patients with glioblastoma (grade IV
glioma [GBM]) have a low 5-year survival rate of 5.5%. In this study, the authors tried to …
glioma [GBM]) have a low 5-year survival rate of 5.5%. In this study, the authors tried to …
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies
Multiple genomic and proteomic studies have suggested that peripheral blood mononuclear
cells (PBMCs) respond to tumor secretomes and thus could provide possible avenues for …
cells (PBMCs) respond to tumor secretomes and thus could provide possible avenues for …
Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
Loco-regional recurrence in 50% of oral squamous cell carcinoma (OSCC) patients poses
major challenge for oncologists. Lack of biomarkers that can predict disease aggressiveness …
major challenge for oncologists. Lack of biomarkers that can predict disease aggressiveness …